Cargando…
Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab
BACKGROUND: Penile squamous cell carcinoma (PSCC) is a rare malignancy, and those patients with metastatic disease have limited treatment options. Treatment is largely comprised of platinum-based chemotherapy; however, patients progressing after initial chemotherapy have a median overall survival (O...
Autores principales: | Chahoud, Jad, Skelton, William Paul, Spiess, Philippe E., Walko, Christine, Dhillon, Jasreman, Gage, Kenneth L., Johnstone, Peter A. S., Jain, Rohit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793656/ https://www.ncbi.nlm.nih.gov/pubmed/33425770 http://dx.doi.org/10.3389/fonc.2020.615298 |
Ejemplares similares
-
An Analysis of Nectin-4 (PVRL4) in Penile Squamous Cell Carcinoma
por: Grass, G.Daniel, et al.
Publicado: (2023) -
An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery
por: Grass, George Daniel, et al.
Publicado: (2023) -
An update on treatment of penile cancer
por: Chadha, Juskaran, et al.
Publicado: (2022) -
The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy
por: Ahmed, Mohamed E., et al.
Publicado: (2020) -
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
por: Adashek, Jacob J., et al.
Publicado: (2021)